Cart
Multiplex Assays Market by Type {Nucleic Acid-Based Multiplex Assays (Planar Nucleic Acid Assays and Bead-Based Nucleic Acid Assays), Protein-Based Multiplex Assays (Planar Protein Assays and Bead-Based Protein Assays)}, Product {Multiplex Assay Reagents & Consumables, Multiplex Assay Accessories & Instruments, and Multiplex Assay Software & Services}, Technology {Multiplex PCR, Multiplex Protein Microarray, and Others}, Application {Companion Diagnostics, Research & Development (Drug Development and Biomarker Discovery & Validation), Clinical Diagnostics (Cancer, Infectious Diseases, Cardiac Diseases, Autoimmune Diseases, Alzheimers Disease, and Others)}, and End User {Hospitals, Clinical Laboratories, Research Institutes, and Pharmaceuticals & Biotechnological Companies} - Global Opportunity Analysis and Industry Forecast, 2014-2022
|
LI_171921
|
Pages: 180
|
Mar
2017 |
4074 Views
|
|
|
|
Author(s) :
Shubhangi Bawakar and Abha Thakur
|
Tables: 50
|
Charts: 46
|
Formats*:
|
|
Multiplex Assays Market Overview:
Multiplex Assays Market was valued at $3,470 million in 2015 and is expected to garner $5,720 million by 2022, registering a CAGR of 7.4% during the forecast period. Multiplex assays is a process that measures multiple analytes simultaneously such as DNA and proteins.
Factors such as rise in number of research & development for treatment of diseases, increase in adoption of multiplex assays to reduce operation costs, technological advancements, and growth in adoption of personalized medicine for increasing safety & efficacy of therapies are expected to create new opportunities for the key players during the analysis period. However, shortage of experienced healthcare professionals and huge capital investments are the major restrains for the market growth.
Global multiplex assays market segmentation
Get more information on this report : Request Sample Pages
Segment review
The global multiplex assays market is categorized based on type into nucleic acid-based multiplex assays and protein-based multiplex assays. The protein-based multiplex assays accounted for the highest market share and is expected to grow with the highest rate during the forecast period. Rise in adoption of protein-based multiplex assays for analyzing the unknown proteins and their functions simultaneously and precisely is the key trend that drives the market.
Top Investment Pocket
Get more information on this report : Request Sample Pages
Geographical review
Geographically, the global multiplex assays market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America held the highest share of the market in 2015, followed by Europe. Asia-Pacific has anticipated to grow at the highest rate during the analysis period. The key factors that drive the growth of this market includes increase in pool of patient population, rise in the prevalence of Alzheimer patients, and significant rise in research & development activities in pharmaceuticals for the treatment of diseases, such as cancer and Alzheimer’s.
Italy Multiplex Assays Market ($Million), 2014-2022
Get more information on this report : Request Sample Pages
Asia-Pacific is expected to emerge as the area with maximum growth potential, owing to focus of key players in the developing countries and improvement in the healthcare infrastructure.
Market Drivers and Restraints
Rise in R&D activities & related funding
Multiplex assays hold high potential in the R&D of drugs for the treatment of diseases, such as cancer and cardiovascular diseases. For instance, bead-based Luminex xMAP multiplex assay provides a platform for the cancer biomarker assays, which is compatible with plasma, serum, cultured cells, and other biological samples. Moreover, the American Association of Cancer Research (AACR) developed multiplex immunoassay that helped in the examination of acquired resistance to receptor tyrosine kinase (RTK) inhibitors. RTK is used as a target for the drug development for the treatment of cancer. Centers for Disease Control and Prevention estimated that in the U.S. one in every four deaths is due to cancer, thus Bio-Rad Laboratories’ Bio-Plex (magnetic bead-based multiplex assay) is developed using Luminex xMAP that help in the quantification of cancer biomarkers. Moreover, the funding for research has increased in both the developed and the developing countries. According to the AACR, 2015, there was a 7% increase in federal funding for the National Cancer Institute (NCI), National Institute of Health (NIH). In the developing countries, such as India, Australia, and Mexico, the government has invested toward the development of healthcare, and the number of clinical laboratories, hospitals, and research centers are increasing.
Technological advancements
The change in technological landscape for R&D and clinical diagnostics have raised the demand for technologically advanced multiplex assays. Recent developments in multiplex assays have the potential to evaluate the complexity of analytes, such as proteins and amino acids, in a better manner. For instance, in 2016, Merck launched MILLIPLEX MAP Equine-specific multiplex assay that can measure 27 cytokines simultaneously and delivers important information about immune response, inflammation, and general health. In clinical laboratories, multiplex assays are expected to interrogate multiple pathogen using a single specimen.
The scarcity of skilled labor/healthcare professionals
The dearth of skilled professionals (technologists and lab technicians) to handle the multiplex assay related tests is the major factor that restrains the market growth. For instance, according to Labor Statistics analyzed by the U.S. Department of Labor’s Bureau there is an inadequacy of lab technicians, and the job for lab technicians is expected to grow by 2022 with a share of 22%. Canada is currently facing a nation-wide shortage of medical laboratory technologists. According to Canadian Society for Medical Laboratory Sciences, half of the laboratory technologists are over the age of 45 years and are expected to retire in next 10 years; hence, there would be a high need for skilled laboratory professionals in R&D and clinical diagnostic sector. There is a shortage of laboratory managers possessing advanced laboratory expertise, experience, and knowledge, specifically in remote healthcare organizations. The demand for multiplex assays has increased to reduce the man-hours required to carry out large number of tests with single plex assays; however, lack of skilled labor to handle multiplex analyzers limits the growth of multiplex assays market.
The top players in this market include Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Becton, Dickinson and Company, Abcam plc., Seegene Inc., Meso Scale Diagnostics, LLC., Randox Laboratories Ltd., The other players in the value chain include Sysmex Corporation, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., and Johnson & Johnson Services, Inc.
Key Benefits:
- The study provides an in-depth analysis of the multiplex assays market with current trends and future estimations to elucidate the imminent investment pockets in the market.
- The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities.
- Extensive analysis by type, product, technology, and application help in understanding the various trends and prevailing opportunities in the respective market.
- Comprehensive analysis of all geographical regions is provided, which assist in determining the main opportunities in these regions.
- Key market players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of global multiplex assays market.
Multiplex Assays Market Key Segment:
By Type
- Nucleic Acid-Based Multiplex Assays
- Planar Nucleic Acid Assays
- Bead-Based Nucleic Acid Assays
- Protein-Based Multiplex Assays
- Planar Protein Assays
- Bead-Based Protein Assays
- Other Multiplex Assays
By Product
- Multiplex Assay Reagents & Consumables
- Multiplex Assay Instruments & Accessories
- Multiplex Assay Software and Services
By Technology
- Multiplex PCR
- Multiplex Protein Microarray
- Other Technologies
By Application
- Companion Diagnostics
- Research & Development
- Drug Development
- Biomarker Discovery and Validation
- Clinical Diagnostics
- Cancer
- Infectious Diseases
- Cardiac Diseases
- Autoimmune Diseases
- Alzheimer’s Disease
- Other Diseases
By End User
- Hospitals
- Clinical Laboratories
- Research Institutes
- Pharmaceuticals & Biotechnological Companies
By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle East
- Africa
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENT
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry
3.4. MARKET SHARE ANALYSIS OF MULTIPLEX ASSAYS MARKET, 2015
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 MULTIPLEX ASSAYS MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market Size and Forecast
4.2. NUCLEIC ACID-BASED MULTIPLEX ASSAYS
4.2.1. Key Market Trends
4.2.2. Key Growth Factors and Opportunities
4.2.3. Market Size and Forecast
4.2.4. Planar Nucleic Acid Multiplex Assays
4.2.5. Bead-Based Nucleic Acid Multiplex Assays
4.3. PROTEIN-BASED MULTIPLEX ASSAYS
4.3.1. Key Market Trends
4.3.2. Key Growth Factors And Opportunities
4.3.3. Market Size and Forecast
4.3.4. Planar Protein Multiplex Assays
4.3.5. Bead-Based Protein Multiplex Assays
4.4. OTHER MULTIPLEX ASSAYS
4.4.1. Key Market Trends
4.4.2. Key Growth Factors And Opportunities
4.4.3. Market Size And Forecast
CHAPTER 5 MULTIPLEX ASSAYS MARKET, BY PRODUCT
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. MULTIPLEX ASSAYS REAGENTS & CONSUMABLES
5.2.1. Market size and forecast
5.3. MULTIPLEX ASSAYS INSTRUMENTS AND ACCESSORIES
5.3.1. Market size and forecast
5.4. MULTIPLEX ASSAY SOFTWARE AND SERVICES
5.4.1. Market size and forecast
CHAPTER 6 MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. MULTIPLEX PCR
6.2.1. Market size and forecast
6.3. MULTIPLEX PROTEIN MICROARRAY
6.3.1. Market size and forecast
6.4. OTHER TECHNOLOGIES
6.4.1. Market size and forecast
CHAPTER 7 MULTIPLEX ASSAYS MARKET, BY APPLICATION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. COMPANION DIAGNOSTICS
7.2.1. Market size and forecast
7.3. RESEARCH & DEVELOPMENT
7.3.1. Market size and forecast
7.3.2. Drug Development: Market Size and Forecast
7.3.3. Biomarker Discovery and Validation: Market Size and Forecast
7.4. CLINICAL DIAGNOSTICS
7.4.1. Market size and forecast
7.4.2. Cancer: Market Size and Forecast
7.4.3. Infectious Diseases: Market Size and Forecast
7.4.4. Cardiac Diseases: Market Size and Forecast
7.4.5. Autoimmune Diseases: Market Size and Forecast
7.4.6. Alzheimers Disease: Market Size and Forecast
7.4.7. Other Diseases: Market Size and Forecast
CHAPTER 8 MULTIPLEX ASSAYS MARKET, BY END USER
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. HOSPITALS
8.2.1. Market size and forecast
8.3. CLINICAL LABORATORIES
8.3.1. Market size and forecast
8.4. RESEARCH INSTITUTES
8.4.1. Market size and forecast
8.5. PHARMACEUTICALS & BIOTECHNOLOGICAL COMPANIES
8.5.1. Market size and forecast
CHAPTER 9 MULTIPLEX ASSAYS MARKET, BY GEOGRAPHY
9.1. OVERVIEW
9.1.1. Market size and forecast
9.2. NORTH AMERICA
9.2.1. Key market trends
9.2.2. Key growth factors and opportunities
9.2.3. Market size and forecast
9.2.4. U.S. market size and forecast
9.2.5. Canada market size and forecast
9.2.6. Mexico market size and forecast
9.3. EUROPE
9.3.1. Key market trends
9.3.2. Key growth factors and opportunities
9.3.3. Market size and forecast
9.3.4. Germany market size and forecast
9.3.5. France market size and forecast
9.3.6. UK market size and forecast
9.3.7. Italy market size and forecast
9.3.8. Spain market size and forecast
9.3.9. Rest of Europe market size and forecast
9.4. ASIA-PACIFIC
9.4.1. Key market trends
9.4.2. Key growth factors and opportunities.
9.4.3. Market size and forecast
9.4.4. Japan market size and forecast
9.4.5. China market size and forecast
9.4.6. India market size and forecast
9.4.7. Rest of Asia-Pacific market size and forecast
9.5. LAMEA
9.5.1. Key market trends
9.5.2. Key growth factors and opportunities
9.5.3. Market size and forecast
9.5.4. Latin America market size and forecast
9.5.5. Middle East market size and forecast
9.5.6. Africa market size and forecast
CHAPTER 10 COMPANY PROFILES
10.1. LUMINEX CORPORATION
10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Operating business segments
10.1.4. Product portfolio
10.1.5. Business performance
10.1.6. Key strategic moves and developments
10.2. THERMO FISHER SCIENTIFIC, INC.
10.2.1. Company overview
20.2.2. Company snapshot
20.2.3. Operating business segments
20.2.4. Product portfolio
20.2.5. Business performance
20.2.6. Key strategic moves and developments
10.3. ILLUMINA, INC.
10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Product portfolio
10.3.5. Business performance
10.3.6. Key strategic moves and developments
10.4. BIO-RAD LABORATORIES, INC.
10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Operating business segments
10.4.4. Product portfolio
10.4.5. Business performance
10.4.6. Key strategic moves and developments
10.5. QIAGEN N.V.
10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Product portfolio
10.5.5. Business performance
10.5.6. Key strategic moves and developments
10.6. BECTON, DICKINSON AND COMPANY
10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Product portfolio
10.6.5. Business performance
10.6.6. Key strategic moves and developments
10.7. ABCAM PLC
10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Product portfolio
10.7.5. Business performance
10.7.6. Key strategic moves and developments
10.8. SEEGENE INC.
10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Operating business segments
10.8.4. Product portfolio
10.8.5. Business performance
10.8.6. Key strategic moves and developments
10.9. MESO SCALE DIAGNOSTICS, LLC
10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Product portfolio
10.9.5. Business performance
10.9.6. Key strategic moves and developments
10.10. RANDOX LABORATORIES LTD.
10.10.1. Company overview
10.10.2. Company snapshot
10.10.3. Operating business segments
10.10.4. Product portfolio
10.10.5. Business performance
10.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL MULTIPLEX ASSAYS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 2. GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 3. GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 4. GLOBAL PROTEIN-BASED MULTIPLEX ASSAYS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 5. GLOBAL PROTEIN-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 6. GLOBAL OTHER MULTIPLEX ASSAYS MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 7. GLOBAL MULTIPLEX ASSAYS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 8. GLOBAL MULTIPLEX ASSAY REAGENTS & CONSUMABLES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 9. GLOBAL MULTIPLEX ASSAY INSTRUMENTS & ACCESSORIES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 10. GLOBAL MULTIPLEX ASSAY SOFTWARE AND SERVICES MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 11. GLOBAL MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 12. GLOBAL MULTIPLEX ASSAYS MARKET FOR MULTIPLEX PCR, BY REGION, 2014-2022 ($MILLION)
TABLE 13. GLOBAL MULTIPLEX ASSAYS MARKET FOR PROTEIN MICROARRAY, BY REGION, 2014-2022 ($MILLION)
TABLE 14. GLOBAL MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2014-2022 ($MILLION)
TABLE 15. GLOBAL MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 16. GLOBAL MULTIPLEX ASSAYS MARKET FOR COMPANION DIAGNOSTICS, BY REGION, 2014-2022 ($MILLION)
TABLE 17. GLOBAL MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2014-2022 ($MILLION)
TABLE 18. GLOBAL MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2014-2022 ($MILLION)
TABLE 19. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2014-2022 ($MILLION)
TABLE 20. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2014-2022 ($MILLION)
TABLE 21. GLOBAL MULTIPLEX ASSAYS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 22. GLOBAL MULTIPLEX ASSAYS MARKET FOR HOSPITALS, BY REGION, 2014-2022 ($MILLION)
TABLE 23. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2014-2022 ($MILLION)
TABLE 24. GLOBAL MULTIPLEX ASSAYS FOR RESEARCH INSTITUTES, BY REGION, 2014-2022 ($MILLION)
TABLE 25. GLOBAL MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGICAL COMPANIES, BY REGION, 2014-2022 ($MILLION)
TABLE 26. GLOBAL MULTIPLEX ASSAYS MARKET, BY REGION, ($MILLION), 2014-2022
TABLE 27. NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY COUNTRY, ($MILLION), 2014-2022
TABLE 28. NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TYPE, ($MILLION), 2014-2022
TABLE 29. NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY PRODUCT, ($MILLION), 2014-2022
TABLE 30. NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, ($MILLION), 2014-2022
TABLE 31. NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY APPLICATION, ($MILLION), 2014-2022
TABLE 32. NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY END USER, ($MILLION), 2014-2022
TABLE 33. EUROPE: MULTIPLEX ASSAYS MARKET, BY COUNTRY, ($MILLION), 2014-2022
TABLE 34. EUROPE: MULTIPLEX ASSAYS MARKET, BY TYPE, ($MILLION), 2014-2022
TABLE 35. EUROPE: MULTIPLEX ASSAYS MARKET, BY PRODUCT, ($MILLION), 2014-2022
TABLE 36. EUROPE: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, ($MILLION), 2014-2022
TABLE 37. EUROPE: MULTIPLEX ASSAYS MARKET, BY APPLICATION, ($MILLION), 2014-2022
TABLE 38. EUROPE: MULTIPLEX ASSAYS MARKET, BY END USER ($MILLION), 2014-2022
TABLE 39. ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET, BY COUNTRY, ($MILLION), 2014-2022
TABLE 40. ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET, BY TYPE, ($MILLION), 20142022
TABLE 41. ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET, BY PRODUCT, ($MILLION), 2014-2022
TABLE 42. ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, ($MILLION), 2014-2022
TABLE 43. ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET, BY APPLICATION, ($MILLION), 2014-2022
TABLE 44. ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET, BY END USER, ($MILLION), 2014-2022
TABLE 45. LAMEA: MULTIPLEX ASSAYS MARKET, BY COUNTRY, ($MILLION), 2014-2022
TABLE 46. LAMEA: MULTIPLEX ASSAYS MARKET, BY TYPE, ($MILLION), 20142022
TABLE 47. LAMEA: MULTIPLEX ASSAYS MARKET, BY PRODUCT, ($MILLION), 2014-2022
TABLE 48. LAMEA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, ($MILLION), 2014-2022
TABLE 49. LAMEA: MULTIPLEX ASSAYS MARKET, BY APPLICATION, ($MILLION), 2014-2022
TABLE 50. LAMEA: MULTIPLEX ASSAYS MARKET, BY END USER, ($MILLION), 2014-2022
LIST OF FIGURES
FIGURE 1. MULTIPLEX ASSAYS: MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. MARKET SHARE ANALYSIS OF MULTIPLEX ASSAYS, 2015
FIGURE 6. PLANAR NUCLEIC ACID MULTIPLEX ASSAYS MARKET, 2014-2022 ($MILLION)
FIGURE 7. BEAD-BASED NUCLEIC ACID MULTIPLEX ASSAYS MARKET, 2014-2022 ($MILLION)
FIGURE 8. PLANAR PROTEIN MULTIPLEX ASSAYS MARKET, 2014-2022 ($MILLION)
FIGURE 9. BEAD-BASED PROTEIN MULTIPLEX ASSAYS MARKET, 2014-2022 ($MILLION)
FIGURE 10. GLOBAL MULTIPLEX ASSAYS MARKET FOR DRUG DEVELOPMENT, 2014-2022 ($MILLION)
FIGURE 11. GLOBAL MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY AND VALIDATION, 2014-2022 ($MILLION)
FIGURE 12. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS OF CANCER, 2014-2022 ($MILLION)
FIGURE 13. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS OF INFECTIOUS DISEASES, 2014-2022 ($MILLION)
FIGURE 14. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS OF CARDIAC DISEASES, 2014-2022 ($MILLION)
FIGURE 15. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS OF AUTOIMMUNE DISEASES, 2014-2022 ($MILLION)
FIGURE 16. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS OF ALZHEIMERS DISEASE, 2014-2022 ($MILLION)
FIGURE 17. GLOBAL MULTIPLEX ASSAYS MARKET FOR CLINICAL DISGNOSTICS OF OTHER DISEASES, 2014-2022 ($MILLION)
FIGURE 18. U.S. HEALTHCARE EXPENDITURE BY GDP (%)
FIGURE 19. U.S.: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 20. CANADA: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 21. MEXICO: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 22. EUROPE HEALTHCARE EXPENDITURE BY GDP (%)
FIGURE 23. GERMANY: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 24. FRANCE: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 25. UK: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 26. ITALY: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 27. SPAIN: MULTIPLEX ASSAYS MARKET, ($MILLION), 20142022
FIGURE 28. REST OF EUROPE: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 29. GDP OF ASIAN COUNTRIES ($TRILLION), 2016
FIGURE 30. JAPAN: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 31. CHINA: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 32. INDIA: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 33. REST OF ASIA-PACIFIC: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 34. LATIN AMERICA: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 35. MIDDLE EAST: MULTIPLEX ASSAYS MARKET, ($MILLION), 2014-2022
FIGURE 36. AFRICA: MULTIPLEX ASSAYS MARKET ($MILLION), 2014-2022
FIGURE 37. LUMINEX CORPORATION: COMPANY SNAPSHOT
FIGURE 38. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
FIGURE 39. ILLUMINA, INC.: COMPANY SNAPSHOT
FIGURE 40. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 41. QIAGEN N.V.: COMPANY SNAPSHOT
FIGURE 42. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 43. ABCAM PLC, SEEGENE INC.: COMPANY SNAPSHOT
FIGURE 44. MESO SCALE DIAGNOSTICS, LLC: COMPANY SNAPSHOT
FIGURE 45. RANDOX LABORATORIES LTD.: COMPANY SNAPSHOT
FIGURE 46. SEEGENE INC.: COMPANY SNAPSHOT
The global multiplex assays market is driven by increase in pool of patient population, rise in prevalence of Alzheimer patients, and significant rise in research & development activities in pharmaceuticals for the treatment of diseases, such as cancer and Alzheimer’s. The North American region accounted for the highest market share, owing to availability of ample government funds and increase in prevalence of chronic diseases, such as cancer and strokes Moreover, increase in cases of virus outbreaks in North America stimulates the demand for virus specific multiplex assay, only to identify degree of infection caused by specific viruses. For instance, in 2016, Luminex (U.S.) launched multiplex nucleic acid test to identify Zika virus infection. Technological advancement in this market is expected to create new opportunities during the forecast period.
Asia-Pacific has the highest market potential and the highest growth rate during the analysis period, owing to the increase in per capita income in India and China. Government initiatives for the improvement of healthcare sector and rise in focus of leading manufacturers on expanding their geographic presence in emerging Asia-Pacific countries have captured high growth opportunities in the market. Major companies involved in the multiplex assays market globally are Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., and others.
Download Sample
Purchase Full Report of
Multiplex Assays Market- Global Opportunity Analysis and Industry Forecast, 2014-2022
- Online Only
- $3565
- Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
- $3961
- Restricted to one authorized user
- One print only
- Available in Excel
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
- $5540
- Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
- $6654
- Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF - $9280
- Unlimited within company/enterprise
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Buy Full Version
"Multiplex Assays Market"
Purchase Enquiry